# Smart rTMS

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/smart-rtms

- Industry: Healthcare Specialists
- Headquarters: London, UK
- Website: www.smarttms.co.uk
- Total disclosed funding: $1.1M
- Latest round: Seed (Oct 8, 2019)
- Investors on record: 1

## About

Smart rTMS Limited provides Transcranial Magnetic Stimulation (TMS) therapy, a non-invasive treatment aimed at improving mental health outcomes for conditions such as depression and anxiety through targeted neural stimulation.Founded in 2015, Smart rTMS Limited specializes in TMS therapy, aimed at alleviating symptoms of mental health conditions. The company is headquartered in London, UK and has undergone no known business pivots or structural changes. Gerard Barnes serves as both the founder and CEO. The company has raised GBP 0.55 million in its SEED round in October 2019, primarily from investor Salica Investments, bringing the total amount raised to GBP 0.55 million with a current company valuation of GBP 4.15 million.Smart TMS specializes in Transcranial Magnetic Stimulation (TMS) therapy, which is a non-invasive treatment designed to alleviate symptoms of various mental health conditions such as depression, anxiety, obsessive-compulsive disorder (OCD), and addiction. The therapy functions by stimulating specific brain pathways to promote neural activity and improve mood and cognitive functions. Smart TMS has tailored its offerings to cater to the needs of individuals seeking effective treatment options, providing sessions that typically last 30 minutes and require no hospitalization. The company's services are accessible across multiple locations in the UK and Ireland, targeting a diverse client base that includes individuals struggling with mental health issues, mental health professionals, and private medical insurers supporting treatment costs. Since its inception in 2015, Smart TMS has established itself as the largest provider of TMS therapy in the region, contributing to significant improvements in the quality of life for over a thousand patients.Smart TMS generates revenue primarily through direct-to-consumer transactions for its TMS therapy sessions, which involve flexible pricing structures based on the number of treatments needed, typically ranging from 15 to 30 sessions tailored to individual patient requirements. The company engages with private medical insurers to facilitate coverage for its services, expanding access to patients who may otherwise face financial barriers to treatment. By offering free consultations and utilizing a suitability checker on their website, Smart TMS establishes an initial relationship with potential clients, positioning their TMS therapy as a viable solution for mental health recovery. The revenue model is contingent on the successful delivery of TMS sessions, aligning the company’s financial performance with patient outcomes and satisfaction.Following its most recent funding round in October 2019, where Smart rTMS Limited raised GBP 0.55 million, the company plans to utilize this funding to enhance its service offerings and expand into new geographic regions. Specific markets targeted for expansion have not been disclosed. The funding will support the development of additional products aimed at further improving patient care and accessing a broader client base.

## Funding rounds

- Seed, Oct 8, 2019, $0.7M — Salica Investments
- Seed, Jul 26, 2018, $0.4M — Salica Investments

## Investors

- Salica Investments (https://capitalatlas.ai/funds/salica-investments) — Seed